Patent Assignment
Reel/Frame 055256/0976
Assignment of Assignor's Interest
Recorded: 2021-02-08
Pages: 20
Assignor
PROMETHEUS BIOSCIENCES, INC.
Executed: 2020-12-31
Assignee
PROMETHEUS LABORATORIES, INC.
9410 CARROLL PARK DRIVE, SAN DIEGO, CALIFORNIA, 92121
Covered Properties
(61)
Methods of Diagnosing Liver Fibrosis
PCT:
PCT/US2003/006038 ↗
Methods of Diagnosing Tissue Fibrosis
PCT:
PCT/US2004/035766 ↗
Methods of Diagnosing Inflammatory Bowel Disease
PCT:
PCT/US2005/016965 ↗
Methods of Diagnosing Inflammatory Bowel Disease
PCT:
PCT/US2006/046136 ↗
Inflammatory Bowel Disease Prognostics
PCT:
PCT/US2010/030934 ↗
Assays for the Detection of Anti-Tnf Drugs and Autoantibodies
PCT:
PCT/US2010/054125 ↗
Methods for Improving Inflammatory Bowel Disease Diagnosis
PCT:
PCT/US2012/061202 ↗
Assessment and Monitoring of Mucosal Healing in Children and Adults with Crohn's Disease
PCT:
PCT/US2019/064224 ↗
Inflammatory Bowel Disease First Step Assay System
Patent:
6,218,129 →
Application:
09/079,435 →
Method of Determining Thiopurine Methyltransferase Activity
Methods of Diagnosing Liver Fibrosis
Method of Determining Thiopurine Methyltransferase Acitivity
Methods of diagnosing liver fibrosis
Application:
10/504,544 →
Publication:
US 2006/0084057
Methods of Diagnosing Tissue Fibrosis
Methods of Diagnosing Inflammatory Bowel Disease
Methods of Diagnosing Inflammatory Bowel Disease
Methods of Diagnosing Inflammatory Bowel Disease
Application:
11/841,699 →
Publication:
US 2008/0182280
Methods of Diagnosing Tissue Fibrosis
Application:
12/695,126 →
Publication:
US 2010/0317022
A Method for Determining the Risk of Crohn's Disease-Related Complications
Methods of Diagnosing Inflammatory Bowel Disease
Inflammatory Bowel Disease Prognostics
Application:
13/283,511 →
Publication:
US 2012/0171672
Assays for the Detection of Anti-Tnf Drugs and Autoantibodies
Methods for Improving Inflammatory Bowel Disease Diagnosis
Assays for Detecting Autoantibodies to Anti-Tnfalpha Drugs
Application:
13/961,841 →
Publication:
US 2014/0045276
Assays for the Detection of Anti-Tnf Drugs and Autoantibodies
Methods of Disease Activity Profiling for Personalized Therapy Management
Methods for Improving Inflammatory Bowel Disease Diagnosis
Application:
14/229,715 →
Publication:
US 2015/0072879
Assays for the Detection of Anti-Tnf Drugs and Autoantibodies
Methods for Predicting and Monitoring Mucosal Healing
Application:
14/678,455 →
Publication:
US 2015/0355195
Assays for the Detection of Anti-TNF Drugs and Autoantibodies
Indirect Homogeneous Mobility Shift Assays for the Detection of Biologics in Patient Samples
Methods of Disease Activity Profiling for Personalized Therapy Management
Assays for the Detection of Anti-Tnf Drugs and Autoantibodies
Application:
16/460,597 →
Publication:
US 2020/0018751
Indirect Homogeneous Mobility Shift Assays for the Detection of Biologics in Patient Samples
Methods for Assessing Mucosal Healing in Crohn's Disease Patients
Method of determining thiopurine methyltransferase activity
Application:
60/205,695 →
Methods of diagnosing tissue fibrosis
Application:
60/514,034 →
Inflammatory bowel disease assay system
Application:
60/571,216 →
Methods of diagnosing inflammatory bowel disease
Application:
60/934,919 →
Publication:
US 2006/0154276
Methods of Inflammatory Bowel Disease Prognosis and Biological Response Prediction
Application:
61/169,230 →
Methods of Inflammatory Bowel Disease Prognosis and Biological Response Prediction
Application:
61/178,454 →
Methods to Predict Probability for Surgery in Crohn's Disease Patients
Application:
61/220,453 →
Development of Assays for the Detection of Anti-Tnf Drugs and Autoantibodies
Application:
61/255,048 →
Methods to Predict Probability for Surgery in Crohn's Disease Patients
Application:
61/255,066 →
Development of Assays for the Detection of Anti-Tnf Drugs and Autoantibodies
Application:
61/262,877 →
Inflammatory Bowel Disease Prognostics
Application:
61/262,903 →
Inflammatory Bowel Disease Prognostics
Application:
61/265,324 →
Methods for Prediction of Inflammatory Bowel Disease (Ibd) Using Serologic Markers
Application:
61/265,723 →
Inflammatory Bowel Disease Prognostics
Application:
61/286,356 →
Inflammatory Bowel Disease Prognostics
Application:
61/300,787 →
Inflammatory Bowel Disease Prognostics
Application:
61/302,066 →
Development of Assays for the Detection of Anti-Tnf Drugs and Autoantibodies
Application:
61/324,635 →
Development of Assays for the Detection of Anti-Tnf Drugs and Autoantibodies
Application:
61/345,567 →
Development of Assays for the Detection of Anti-Tnf Drugs and Autoantibodies
Application:
61/351,269 →
Development of Assays for the Detection of Anti-Tnf Drugs and Autoantibodies
Application:
61/389,672 →
Development of Assays for the Detection of Anti-Tnf Drugs and Autoantibodies
Application:
61/393,581 →
Methods for Improving Inflammatory Bowel Disease Diagnosis
Application:
61/550,293 →
Methods for Improving Inflammatory Bowel Disease Diagnosis
Application:
61/553,853 →
Methods for Improving Inflammatory Bowel Disease Diagnosis
Application:
61/567,096 →
Methods for Improving Inflammatory Bowel Disease Diagnosis
Application:
61/570,271 →
Multi-Protein Serum Test Predicts Mucosal Healing in Children with Ileocolonic Crohn's Disease
Application:
62/775,039 →
Related Assignments
(14)
Other recorded transfers of the patents in this record — the chain of ownership.
Corrective Assignment to Correct the Application Number Previously Recorded on Reel 028405 Frame 0480. Assignor(S) Hereby Confirms the Recorded Application Number 13441737. Please Change Application Number to 13441727.
Jun 25, 2012
From: SINGH, SHARAT; WANG, SHUI LONG; OHRMUND, LINDA
To: PROMETHEUS LABORATORIES INC.
Reel/Frame 028555/0907 →
Assignment of Assignor's Interest
Oct 15, 2012
From: PROMETHEUS LABORATORIES INC.
To: NESTEC S.A.
Reel/Frame 029132/0045 →
Assignment of Assignor's Interest
Dec 19, 2012
From: PROMETHEUS LABORATORIES INC.
To: NESTEC S.A.
Reel/Frame 029504/0740 →
Assignment of Assignor's Interest
Oct 21, 2013
From: SINGH, SHARAT; WANG, SHUI LONG; OHRMUND, LINDA; HAUENSTEIN, SCOTT
To: NESTEC S.A.
Reel/Frame 031442/0882 →
Assignment of Assignor's Interest
Mar 21, 2014
From: PRINCEN, FRED; LOCKTON, STEVEN; CRONER, LISA J; FLETCHER, FREDERICK A
To: NESTEC S.A.
Reel/Frame 032502/0181 →
Release of Security Interest
Dec 29, 2015
From: BANK OF AMERICA, N.A.
To: PROMETHEUS LABORATORIES INC.
Reel/Frame 037378/0464 →
Merger
Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →
Corrective Assignment to Correct the English Translation to Show the Full and Correct New Name in Section 51. Previously Recorded at Reel: 049391 Frame: 0756. Assignor(S) Hereby Confirms the Merger.
Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
Merger
Aug 8, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049997/0344 →
Assignment of Assignor's Interest
Aug 26, 2019
From: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
To: PRECISION IBD, INC.
Reel/Frame 050166/0001 →
Change of Name
Oct 17, 2019
From: PRECISION IBD, INC.
To: PROMETHEUS BIOSCIENCES, INC.
Reel/Frame 050886/0942 →
Corrective Assignment to Correct the Patent Number 16062921 Previously Recorded on Reel 049391 Frame 0756. Assignor(S) Hereby Confirms the Patent Number Should Have Been 16062912.
Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
Corrective Assignment to Correct the Patent Number 16062921 Previously Recorded on Reel 049391 Frame 0756. Assignor(S) Hereby Confirms the Patent Number Should Have Been 16062912.
Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
Assignment of Assignor's Interest
Oct 8, 2020
From: MIMMS, LARRY; JAIN, ANJALI
To: PROMETHEUS BIOSCIENCES, INC.
Reel/Frame 054007/0853 →